Windtree Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -46.8% | -46.8% | -28.8% |
| FY2021 | -161.5% | -161.5% | -90.4% |
| FY2022 | -391.6% | -391.6% | -103.3% |
| FY2023 | -598.4% | -598.4% | -62.6% |
| FY2024 | -17.9% | -17.9% | -6.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -46.8% | -46.8% | -28.8% |
| FY2021 | -161.5% | -161.5% | -90.4% |
| FY2022 | -391.6% | -391.6% | -103.3% |
| FY2023 | -598.4% | -598.4% | -62.6% |
| FY2024 | -17.9% | -17.9% | -6.4% |